These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711 [TBL] [Abstract][Full Text] [Related]
64. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium. Demarteau N; Van Kriekinge G; Simon P Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952 [TBL] [Abstract][Full Text] [Related]
65. The potential population-based impact of an HPV vaccination intervention in Colorado. Cataldi JR; Håbesland M; Anderson-Mellies A; Dempsey AF; Cockburn M Cancer Med; 2020 Feb; 9(4):1553-1561. PubMed ID: 31869530 [TBL] [Abstract][Full Text] [Related]
66. Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women. Iversen OE; Miranda MJ; Ulied A; Soerdal T; Lazarus E; Chokephaibulkit K; Block SL; Skrivanek A; Nur Azurah AG; Fong SM; Dvorak V; Kim KH; Cestero RM; Berkovitch M; Ceyhan M; Ellison MC; Ritter MA; Yuan SS; DiNubile MJ; Saah AJ; Luxembourg A JAMA; 2016 Dec; 316(22):2411-2421. PubMed ID: 27893068 [TBL] [Abstract][Full Text] [Related]
67. Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain. Martín-Merino E; Castillo-Cano B; Martín-Perez M; Llorente-García A; Montero-Corominas D Vaccine; 2021 Jul; 39(31):4306-4313. PubMed ID: 34175126 [TBL] [Abstract][Full Text] [Related]
68. Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation. Palmer TJ; Kavanagh K; Cuschieri K; Cameron R; Graham C; Wilson A; Roy K J Natl Cancer Inst; 2024 Jun; 116(6):857-865. PubMed ID: 38247547 [TBL] [Abstract][Full Text] [Related]
69. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark. Hertzum-Larsen R; Thomsen LT; Frederiksen K; Kjær SK Eur J Cancer Prev; 2020 Mar; 29(2):149-156. PubMed ID: 31425314 [TBL] [Abstract][Full Text] [Related]
71. Vaccination Against Human Papillomavirus. Marks DH; Katz KA JAMA Dermatol; 2020 Nov; 156(11):1246-1247. PubMed ID: 32822454 [TBL] [Abstract][Full Text] [Related]
72. Any Number of HPV Vaccine Doses Reduces Risk of Cervical Cancer. Rosenberg K Am J Nurs; 2020 May; 120(5):71. PubMed ID: 32332373 [No Abstract] [Full Text] [Related]
73. Evaluation of the Risk of Inflammatory Bowel Disease after the HPV Vaccination in Primary Care in Spain: A Time-Varying Cohort Analysis of Around 390,000 Girls. Martín-Merino E; Castillo-Cano B; Martín-Pérez M; Llorente-García A; Montero-Corominas D Drug Saf; 2021 Apr; 44(4):455-466. PubMed ID: 33462777 [TBL] [Abstract][Full Text] [Related]
74. The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis. Deleré Y; Wichmann O; Klug SJ; van der Sande M; Terhardt M; Zepp F; Harder T Dtsch Arztebl Int; 2014 Sep; 111(35-36):584-91. PubMed ID: 25249360 [TBL] [Abstract][Full Text] [Related]
76. Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017. Hubbard D; Shrestha S; Levitan EB; Yun H Am J Public Health; 2020 Mar; 110(3):385-390. PubMed ID: 31944848 [No Abstract] [Full Text] [Related]
77. Effective HPV Vaccination Strategies: What Does the Evidence Say? An Integrated Literature Review. Holloway GL J Pediatr Nurs; 2019; 44():31-41. PubMed ID: 30683279 [TBL] [Abstract][Full Text] [Related]
78. Explaining variation in the uptake of HPV vaccination in England. Kumar VM; Whynes DK BMC Public Health; 2011 Mar; 11():172. PubMed ID: 21426539 [TBL] [Abstract][Full Text] [Related]
79. A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005-2022). Bumatay S; Dickinson C; Larsen R; Stock I; Day MR; Hatch B; Robison S; Darden PM; Sullivan E; Carney PA Vaccine; 2023 Sep; 41(39):5758-5762. PubMed ID: 37573204 [TBL] [Abstract][Full Text] [Related]
80. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Fiks AG; Grundmeier RW; Mayne S; Song L; Feemster K; Karavite D; Hughes CC; Massey J; Keren R; Bell LM; Wasserman R; Localio AR Pediatrics; 2013 Jun; 131(6):1114-24. PubMed ID: 23650297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]